Jean Jacques Bienaime - Insider Trading & Ownership

Entity
Individual
Location
925 Page Mill Road, Palo Alto, CA
Summary
The estimated net worth of Jean Jacques Bienaime is at least $56.9M dollars as of August 19, 2024. Jean Jacques Bienaime is the Director of BIOMARIN PHARMACEUTICAL INC and owns shares of BIOMARIN PHARMACEUTICAL INC (BMRN) stock worth about $55.6M. Jean Jacques Bienaime is the Director of INCYTE CORP and owns shares of INCYTE CORP (INCY) stock worth about $1.1M. Jean Jacques Bienaime is the Director of Immunome Inc. and owns shares of Immunome Inc. (IMNM) stock worth about $232K. Jean Jacques Bienaime is the Director of Keros Therapeutics, Inc. and owns shares of Keros Therapeutics, Inc. (KROS) stock worth about $9.06K.
All Insider Reports
All Insider Reports

Ownership of Jean Jacques Bienaime

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BMRN BIOMARIN PHARMACEUTICAL INC Director $55.6M -$11.8M -17.5% May 20, 2024
INCY INCYTE CORP Director $1.1M Jun 12, 2024
IMNM Immunome Inc. Director $232K +$125K +117% Aug 15, 2024
KROS Keros Therapeutics, Inc. Director $9.06K Jun 3, 2024

Insider Transactions Reported by Jean Jacques Bienaime:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.